MarketPR
Injective's INJ token is priced at $4.88, with aggregated analyst forecasts from Wallet Investor, CoinCodex, Changelly, and CoinPedia projecting a 2025 trading range of $9.53 to $10.45 — an average target of $9.89 that implies a 6.36% return on investment for long traders.
The analysis, authored by Caden Pok for Benzinga, pinpoints January 2026 as a potentially volatile stretch before mapping a longer bearish drift toward a 2030 range of $3.91 to $4.90, average $4.34.
The Business Injective Is Building Injective is a Layer-1 blockchain purpose-built for decentralized finance, running on the Cosmos network and designed to support decentralized exchanges, derivatives platforms, and lending protocols.
Its core commercial differentiator is a fully decentralized order book — a structure familiar to traditional traders — paired with cross-chain connectivity to Ethereum and Cosmos that expands the pool of accessible liquidity.
Keep reading